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Extract of Rabdosia amethystoides (Benth) Hara (ERA), a traditional Chinese medicine has antibacterial,
antiviral, anti-tumor, anti-hepatitis and anti-inﬂammatory properties. However, the hepatoprotective
effects and molecular mechanisms of ERA on acute liver injury have not been fully elucidated. This study
aims to investigate the anti-inﬂammatory effect and liver protection of ERA against the acute liver injury
induced by Concanavalin A (Con A) and its underlying molecular mechanisms in mice. Mice received ERA
(50, 100, 150 mg/kg body weight) by gavage before Con A intravenous administration. We found that ERA
pretreatment was able to signiﬁcantly reduce the elevated serum alanine and aspartate aminotransferase
levels and liver necrosis in Con A-induced hepatitis. In addition, ERA treatment signiﬁcantly decreased
the myeloperoxidase, malondialdehyde levels and augmented superoxide dismutase level in the liver
tissue, and also suppressed the secretion of proinﬂammatory cytokines in the serum, compared with Con
A group by enzyme linked immunosorbent assay. Furthermore, we observed that ERA pretreatment can
signiﬁcantly decrease the expression level of Toll-like receptor (TLR) 4 mRNA or protein in liver tissues.
Further results showed that ERA pretreatment was capable of attenuating the activation of the NF-kB
pathway by inhibiting IkBa kinase and p65 phosphorylation in Con A-induced liver injury. Our results
demonstrate that ERA pretreatment has hepatoprotective property against Con A-induced liver injury
through inhibition of inﬂammatory mediators in mice. The beneﬁcial effect of ERA may be mediated by
the downregulation of TLR4 expression and the inhibition of NF-kB activation.
© 2016 Japanese Pharmacological Society. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Liver diseases are still a serious public health problem world-
wide because of signiﬁcant morbidity and mortality. A growing
body of evidence suggests that an immune-mediated mechanism
plays a central role in the development of liver disease, even in
determining its prognosis (1,2). The patient undergoes the pro-
gressive destruction of the hepatic parenchyma and hyper-
gammaglobulinemia, which is characterized by the ﬁltration of
activated T cells in liver (3). The high level of proinﬂammatory.
, szxydh@163.com (H. Duan).
rmacological Society.
. Production and hosting by Elsecytokines such as tumor necrosis factor-a (TNF-a), interferon-g
(IFN-g), and interleukin-6 (IL-6) is induced in liver diseases (4),
including autoimmune hepatitis, acute liver failure and viral, bowel
ischemia and postoperative liver, and sepsis (5). Excessive pro-
duction of proinﬂammatory factors induces inﬂammation and is
associated with the development and aggravation of hepatitis and
with increased morbidity and mortality (6).
Concanavalin A (Con A)-induced speciﬁc liver injury in mice is a
well reliable animal model that closely mimics the pathological
processes and pathogenic mechanisms with viral and autoimmune
hepatitis in human (7). Con A has the ability to activate T cells to
secrete a variety of hepatotoxic cytokines (8,9), i.e., TNF-a, IFN-g
and IL-6, which contribute to the development of hepatocyte
damage (10,11).
Toll-like receptors (TLRs) are widely expressed on multiple he-
patocytes such as Kupffer cells, hepatic stellate cells, hepatocytes,vier B.V. This is an open access article under the CC BY-NC-ND license (http://
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dendritic cells (12), which play critical roles in the liver health (13).
Recent studies indicate that TLR medicated signals have been
involved in almost all liver diseases (14e16), and many therapeutic
agents that abrogate liver injury might transect with the TLR4
signaling pathway (17,18). Furthermore, some studies showed that
TLR4 was critically involved in the pathogenesis of Con A-induced
liver damage (19,20). It had been reported that Con A also upre-
gulated NF-kB expression in liver (21), and there was increasing
evidence shown that Con A-induced liver injury was signiﬁcantly
attenuated via inhibiting NF-kB activation (22,23) Therefore, inhi-
bition of the expression of TLR4 and suppressing the activation of
NF-kB pathway may well represent therapeutic targets for T cell-
mediated hepatitis.
Rabdosia amethystoides (Benth) Hara (usually calledWangzaozi),
belonging to new rabdosia species, is a special traditional Chinese
herbal medicine. Traditionally, the root from R. amethystoides has
been widely used as a medicine for hepatitis and reported to have
antiviral activity, antibacterial, anti-inﬂammation and anti-tumor
due to the presence of triterpenoids, sterols (24,25). Modern
medicines have little to offer for alleviation of hepatic disease and
treatment of liver disorders. It has been only reported that, several
chemical constitutes from the rabdosia species were evaluated for
its possible hepatoprotective activity against chemical induced liver
damage in experimental animals (26). However, the effects of
Extract of R. amethystoides (ERA) in immune-mediated liver injury
and its corresponding mechanisms have not been demonstrated
yet.
In the present study, we investigated the protective effect of ERA
on Con A-induced liver injury, and elucidated potential molecular
mechanisms of ERA in Con A-induced hepatitis.2. Materials and methods
2.1. Reagents
Aspartate transaminase (AST), alanine transaminase (ALT),
myeloperoxidase (MPO), malondialdehyde (MDA), and superoxide
dismutase (SOD) assay kits were purchased fromNanjing Jiancheng
Bioengineering Institute (Nanjing, China). Enzyme linked immu-
nosorbent assay (ELISA) kits for TNF-a, INF-g, and IL-6 were pur-
chased from R&D Systems (Minneapolis, MN, USA). Antibodies
against TLR4, phospho-IkBa, IkBa, phospho-p65 and p65 were
purchased from Cell Signaling Technology (Boston, MA, USA). An
antibody against glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) was purchased from Bioworld Technology (St. Louis Park,
MN, USA). Con Awas purchased from SigmaeAldrich (St. Louis, MO,
USA).2.2. Preparation of ERA
Good quality root of R. amethystoides (Chinese herbal medicine:
Wangzaozi) was purchased from Suzhou Kangyuan Pharmaceutical
Co., LTD (lot number: 20140925) and dried in the shade and then
ground into ﬁne powder by pulverization. The dried powder was
extracted in 10 volumes of boiled 75% ethanol for twice. The ob-
tained extract was concentrated and passed in chromatographic
column of macroporous adsorptive resins; the columnwas washed
using 50% ethanol. The 50% ethanol suspension was evaporated
under vacuum at 40 C and stored for use (ERA). The yield of the
ERA is about 7.55% weight of R. amethystoides. ERA ﬁngerprinting
was performed using high-performance liquid chromatography-
eultraviolet detector (Supplementary Fig. 1). The two compounds
were used as references as follows: oleanolic acid and ursolic acid.2.3. Animal and experimental design
Male ICR mice (18e22 g body weight) were purchased from
the Laboratory Animal Center of Yangzhou University (Yangzhou,
China). The mice were housed in a controlled room temperature
(23 ± 2 C), humidity (55 ± 5%), and kept with a standard lab-
oratory diet, allowed free access to tap water, and a 12-h light/
dark cycle. All mice received humane care in compliance with the
institutional animal care guidelines approved by the Experi-
mental Animal Ethical Committee of Suzhou University (Suzhou,
China).
Ninetymicewere randomly divided into 6 experimental groups:
(1) vehicle control (2), control þ high dose of ERA (150 mg/kg) (3),
Con A (Con A treated) (4), Con A (Con A treated) þ low dose of ERA
(50 mg/kg) (5), Con A (Con A treated) þ median dose of ERA
(100 mg/kg), and (6) Con A (Con A treated) þ high dose of ERA
(150 mg/kg). ERA (50, 100 or 150 mg/kg) was administered orally
using oral gavages once daily during 7 days and 3 h before Con A
injection. The mice received an intravenous Con A injection at the
dose of 15 mg/ml/kg body weight. Mice were anesthetized lethally
at 2, 8, and 24 h after Con A administration. The blood samples were
collected using a tube and then centrifuged. The separated serum
was used for analysis of hepatic enzymes and cytokines. Liver tissue
was harvested for histochemical analysis, protein and gene
analysis.2.4. Serum biochemical analysis
The blood samples obtained were kept at room temperature for
2 h. Serum was then collected after centrifugation at 1000 g for
15 min. Serum ALT and AST were measured with assay kits ac-
cording to the manufacture's instructions.2.5. Histochemical analysis
The liver tissue on 8 h time point was ﬁxed in 4% buffered
paraformaldehyde for at least 24 h. Sections (4e5 mm thick) on
slides were obtained and stained with hematoxylin and eosin
(H&E) for histological observation.2.6. Measurement of MPO, MDA and SOD
From the liver tissue samples on 8 h time point, the liver tissues
(100 mg) were homogenized. The amounts of MPO, MDA and SOD
were determined according to the manufacture's instructions.2.7. Cytokines analysis by ELISA
Serum TNF-a, INF-g, and IL-6 levels were determined by ELISA
kits according to the manufacture's instructions.2.8. Western blotting analysis
Liver sections were carefully homogenized in ice-cold lysis
buffer (Vazyme Biotech, China). After centrifugation, protein con-
centration was determined by BCA protein assay kit (Beyotime
biotechnology, China) with bovine serum albumin as a standard.
Equal amounts of protein extracts were subjected to SDS-PAGE and
then transferred onto PVDF membranes (Millipore Corporation,
Billerica, MA, USA). Membranes were incubated with primary and
secondary antibodies. Protein bands were visualized by ECL reagent
(Vazyme Biotech, China). The densities of the bands were assessed
and normalized to the GAPDH signals.
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Total RNA was isolated from the homogenate of the liver with
Trizol reagent (Invitrogen, Carlsbad, CA, USA) at 8 h after Con A
stimulated. The cDNA was synthesized with a ﬁrst-strand cDNA
synthesis kit (Vazyme Biotech, Nanjing, China) according to the
manufacturer's instruction. For real-time assays, PCR reactions
were prepared in SYBR Green PCR Master Mix (Bio-Rad, Hercules,
CA, USA). DNA targets were ampliﬁed and analyzed with a Bio-Rad
CFX Manager 3.0 system (Bio-Rad, Hercules, CA, USA). The relative
amount of mRNA in each sample was determined using the DDCT
method. The murine primer sequences are shown as follows:
mTLR4 forward, GTGTGAAATTGAGACAATTGAAAAC; mTLR4
reverse, GTTTCCTGTCAGTACCAAGGTTGA; m18S forward,
TGTGATGCCCTTAGATGTCC and m18S reverse,
TGGGGTTCAACGGGTTAC.
2.10. Statistical analysis
All experimental data were expressed as the means ± standard
error of the means (SEM). Signiﬁcant differences among the
experimental groups were determined by the unpaired Student's t-
test or analysis of variance (ANOVA) followed by the Bonferroni's
test. Differences were considered signiﬁcant with a P value of less
than 0.05.
3. Results
3.1. ERA decreased levels of AST and ALT after Con A challenge
The severity of Con A-induced liver injury was determined
through serum AST and ALT level and histological ﬁndings. Serum
levels of AST and ALT drastically increased in response to Con AFig. 1. ERA pretreatment attenuated liver damage followed by Con A administration. The m
days before Con A injection. After each time points of Con A administration, serum was col
points post-Con A injection in mice. Data were shown as mean ± SEM of three independent einjection in mice and reached the maximal level at 8 h after Con A
injection. As shown in Fig. 1, compared with normal or ERA normal,
transaminase levels at the 8 h time-point drastically increased
(P < 0.01), and pretreatment of mice with 150 mg/kg ERA signiﬁ-
cantly suppressed release of the transaminases ALT and AST into
the plasma of Con A treated mice (P < 0.01). ERA did not signiﬁ-
cantly inﬂuence transaminase in normal control mice (Fig. 1A and
B).
3.2. ERA ameliorated Con A-induced liver injury by histological
examination
In addition, the protective effect of ERA pretreatment was
further conﬁrmed by analysis of histological ﬁndings. As shown in
Fig. 2, Con A-treated mice was examined microscopically and
exhibited inﬂammatory inﬁltration around the central veins and
large areas of necrosis within the liver lobules. This histopathologic
liver damage correlated with the elevated serum levels of the liver
enzymes in Fig. 1. However, ERA pretreatment (50, 100 or 150 mg/
kg) dramatically attenuated liver necrosis in a dose-dependent
manner (Fig. 2). These results demonstrated that ERA inhibited
Con A-induced liver cell death in mice.
3.3. ERA pretreatment reduces MPO, MDA levels and augments SOD
level in liver
MPO level was known as an indirect indicator for the recruit-
ment of neutrophils to the infected organs. The biochemical anal-
ysis results showed that MPOwas signiﬁcantly increased in the Con
A-treated mice. ERA pretreatment (50, 100 or 150 mg/kg) dramat-
ically decreased the MPO level in a dose-dependent manner
(Fig. 3A). The extent of lipid peroxidation was showed by mea-
surement of liver MDA level for each treatment group. ERAice (5 mice each group) were pretreated with ERA (150 mg/kg) or PBS once a day for 7
lected by heart puncture. (A and B) ERA reduced levels of AST and ALT at various time
xperiments, ##P < 0.01 vs. normal or ERA normal, **P < 0.01 vs. Con A-injected control.
Fig. 2. Representative microscopic appearances of histopathological changes of mice in every group. The mice (6 mice each group) were pretreated with ERA (50, 100, or 150 mg/kg)
or PBS once a day for 7 days before Con A injection. After 8 h of Con A administration, liver tissues were collected for analysis. (AeF) Photomicrographs of representative livers
obtained 8 h post-Con A injection with H&E staining were shown (original magniﬁcation 100). Saline-injected control animals only received PBS or ERA, and Con A-induced
groups pretreated with PBS or ERA.
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the Con A treated mice (Fig. 3B). The SOD level in the Con A treated
mice was signiﬁcantly decreased compared with that of normal
mice. The SOD level in the ERA pretreated mice was further
increased in a dose-dependent manner compared with that of only
Con A-treated mice (Fig. 3C).
3.4. ERA pretreatment inhibited the release of inﬂammatory
cytokines in serum
Inﬂammatory cytokines play a key role in Con A-induced hep-
atitis. As shown in Fig. 4, the serum levels of TNF-a, INF-g, and IL-6Fig. 3. Effect of ERA on tissue MPO, MDA and SOD levels in mice after Con A challenge. The m
day for 7 days before Con A injection. After 8 h of Con A administration, liver tissues were co
as mean ± SEM of three independent experiments, ##P < 0.01 vs. control; **P < 0.01 vs. Cowere remarkably increased in response to Con A injection at time
point of 8 h. Pretreatment with ERA (50, 100 or 150 mg/kg)
signiﬁcantly reduced levels of TNF-a, INF-g, and IL-6 in a dose-
dependent manner compared to Con A group. Thus, the preven-
tion by ERA of Con A-induced liver injury was also associated with
the inhibition of proinﬂammatory cytokine release.
3.5. ERA pretreatment suppressed TLR4 mRNA and protein levels in
Con A-induced liver injury
TLR4 mRNA expression in the liver tissue was tested by real-
time quantitative reverse transcriptase polymerase chain reactionice (6 mice each group) were pretreated with ERA (50, 100, or 150 mg/kg) or PBS once a
llected for analysis. (A) MPO level. (B) MDA level. (C) SOD level. The results were shown
n A-treated mice.
Fig. 4. Effect of ERA on serum levels of cytokine in Con A-induced liver injury. The mice (6 mice each group) were pretreated with ERA (50, 100, or 150 mg/kg) or PBS once a day for
7 days before Con A injection. After 8 h of Con A administration, serum was collected by heart puncture. (AeC) The concentrations of TNF-a, IFN-g and IL-6 were detected by using
ELISA kits according to the manufacturer's instructions. Data were shown as mean ± SEM of three independent experiments, ##P < 0.01 vs. normal group, **P < 0.01 vs. Con A group.
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decreased in a dose-dependent manner by ERA pretreated
compared with Con A group. Similarly, we also investigated intra-
hepatic TLR4 protein expression at 8 h after Con A injection.
Intrahepatic TLR4 protein levels signiﬁcantly increased upon Con A
injection at 8 h, and reduced by ERA pretreated compared with Con
A group (Fig. 5B).
3.6. ERA inhibited NF-kB pathway in Con A-induced liver injury
The transcription factor NF-kB, which is associated with in-
ﬂammatory response, plays an important role in Con A-induced
liver injury. Therefore, we wondered whether the effect of ERA on
cytokine might be due to its inﬂuence on NF-kB activation in vivo.
As observed in Fig. 6, Con A challenge at time point of 8 h induced
IkBa phosphorylation with IkBa degradation in liver tissue, but
these alterations were reversed by treatment with ERA.Fig. 5. The effect of ERA pretreatment on TLR4 mRNA and protein expression. At 8 h after C
mRNA were determined by qRT-PCR. TLR4 mRNA levels were normalized with GAPDH exp
with GAPDH as an internal control. Data were shown as mean ± SEM of three independenFurthermore, we found that the level of phosphorylation of p65
was remarkably increased in response to Con A injection at time
point of 8 h and ERA pretreatment signiﬁcantly suppressed p65
phosphorylation compared with Con A group.
4. Discussion
R. amethystoides is a traditional herbal medicine that has been
used in Chinese folk for many years. Based upon previous positive
results, we investigated whether ERA has hepatoprotective effect
and its underlying mechanism against Con A-induced acute liver
injury. Our results demonstrated anti-hepatotoxic property of ERA
as evidenced by dose-dependent inhibition of the elevation of
serum AST and ALT levels as well as histopathological ﬁnding
(Figs. 1 and 2).
Oxidative stress is a well-known cause of various hepatic
damages. Recent reports also represented reactive oxygen specieson A challenge, liver tissues (6 mice each group) were harvested. (A) The levels of TLR4
ression in each sample. (B) Hepatic TLR4 protein levels were analyzed by western blot
t experiments, ##P < 0.01 vs. normal group, **P < 0.01 vs. Con A group.
Fig. 6. The effect of ERA pretreatment on NF-kB signaling pathway. At 8 h after Con A challenge, liver tissues (6 mice each group) were harvested. (A) Hepatic NF-kB protein levels
were analyzed by western blot with antibodies against phospho-IkBa, IkBa, phospho-p65, and p65. The GAPDH was used as an internal control. (B) Statistical diagram of phospho-
IkBa, IkBa and phospho-p65. Values were mean ± SEM of three independent experiments, ##P < 0.01 vs. normal group, **P < 0.01 vs. Con A group.
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(27). Therefore, we examined antioxidant effect of ERA in the pre-
sent study. Con A injection induced severe accumulation of MDA
and moderate depletion of SOD in the liver tissue. Our results
showed signiﬁcant reduction of MDA by ERA pretreatment in a
dose-dependent manner, and moderate restoration of SOD (Fig. 3B
and C).
The increased MPO activity is often used as a marker for the
inﬁltration of neutrophils into tissues, and it also indicates the
occurrence of inﬂammation (28). Our results demonstrate that ERA
reduce the increased MPO activity (Fig. 3A) in liver tissue and levels
of inﬂammatory factors in serum (Fig. 4).
Con A has the ability to activate T cells to secrete a variety of
hepatotoxic cytokines (8,9), i.e., TNF-a, IFN-g and IL-6. These cy-
tokines stimulate and activate liver cells which further contribute
to the development of hepatocyte damage through TLRs signal
pathway (10,11). TLRs are a group of receptors that are involved in
innate immunity and inﬂammation. TLRs are involved in liver
ﬁbrosis, caused by many common liver pathogens, such as viral,
parasitic and toxin-induced hepatitis (29). Activation of the TLR4
signal pathway initiates a cascade of events, including translocation
of nuclear factor kappa B (NF-kB) p65 to the nucleus (Fig. 6), leading
to more production and release of inﬂammatory cytokines (TNF-a,
INF-g, and IL-6) (Fig. 4). Due to its strong reduction of TLR4
expression (Fig. 5) and inhibition of NF-kB signaling pathway, we
demonstrate that ERA exhibits anti-inﬂammatory activity. Our re-
sults clearly illustrated that ERA inhibited inﬂammatory cytokines
production which is involved in TLR4-NF-kB signaling. This anti-
inﬂammatory effect may be responsible for the hepatoprotective
effect of ERA.
In Supplementary Fig. 1, oleanolic acid and ursolic acid tri-
terpenoid compounds are checked out in ERA. Oleanolic acid and
ursolic acid are well known about their hepatoprotective effects
for both acute chemically induced liver injury and chronic liver
ﬁbrosis and cirrhosis (30). They are still used alone or in com-
bination with other hepatoprotective components as oral drugs.
The protection of these triterpenes on the liver injury could
attribute to their anti-inﬂammatory and anti-oxidant activities,
and their effects on drug metabolic enzymes. Oleanolic acid and
ursolic acid are believed to be the main active constituents in
ERA.
Taken together, our results demonstrate that ERA attenuates
Con A-induced hepatitis in mice. The hepatoprotective effect of ERA
is due to inhibition oxidative stress and the release of inﬂammatory
mediators including TNF-a, INF-g, and IL-6. In addition, the sup-
pressant effects are associated with the inhibition of TLR4 expres-
sion and NF-kB pathway. These ﬁndings suggest that ERA may have
convincing therapeutic potentials in treating patients with
immune-mediated hepatic diseases.Conﬂict of interest
None.
Acknowledgments
This research work was supported by the Natural Science
Foundation Committee of Anhui Province (No.1608085QH185,
1308085MH136), the Key Natural Science Foundation of Anhui
Educational Committee (No.KJ2015A220, KJ2014A249), the Key
Project Fund for Outstanding Young Talents in Anhui Higher Edu-
cation Institutions (No.gxyqZD2016348), the PhD Research Startup
Foundation of Suzhou University (No.2015jb12), and the Open
Project Program of the Engineering Research Center of Special Farm
Seed Production (No.2015YKF03, 2015YKF06, 2015YKF01) and
Suzhou Regional Development Collaborative Innovation Center
(No.2015SZXTZXKFYB03).
Appendix A. Supplementary data
Supplementary data related to this article can be found at http://
dx.doi.org/10.1016/j.jphs.2015.12.006.
References
(1) Park EJ, Lee JH, Yu GY, He G, Ali SR, Holzer RG, et al. Dietary and genetic
obesity promote liver inﬂammation and tumorigenesis by enhancing IL-6 and
TNF expression. Cell. 2010;140:197e208.
(2) Lin M, Zhai X, Wang G, Tian X, Gao D, Shi L, et al. Salvianolic acid B protects
against acetaminophen hepatotoxicity by inducing Nrf2 and phase II detoxi-
ﬁcation gene expression via activation of the PI3K and PKC signaling path-
ways. J Pharmacol Sci. 2015;127:203e210.
(3) Wan YG, Zhao Q, Sun W, Zhang HL, Li M, Wei QX, et al. Contrasting dose-
eeffects of multi-glycoside of Tripterygium wilfordii HOOK. f. on glomerular
inﬂammation and hepatic damage in two types of anti-Thy1. 1 glomerulo-
nephritis. J Pharmacol Sci. 2012;118:433e446.
(4) Wu D, Bao C, Li L, Fu M, Wang D, Xie J, et al. Chlorogenic acid protects against
cholestatic liver injury in rats. J Pharmacol Sci. 2015;129:177e182.
(5) Kim SH, Cheon HJ, Yun N, Oh ST, Shin E, Shim KS, et al. Protective effect of a
mixture of Aloe vera and Silybum marianum against carbon tetrachloride-
induced acute hepatotoxicity and liver ﬁbrosis. J Pharmacol Sci. 2009;109:
119e127.
(6) Koch A, Gressner OA, Sanson E, Tacke F, Trautwein C. Serum resistin levels in
critically ill patients are associated with inﬂammation, organ dysfunction and
metabolism and may predict survival of non-septic patients. Crit Care.
2009;13:R95.
(7) Kaneko Y, Harada M, Kawano T, Yamashita M, Shibata Y, Gejyo F, et al.
Augmentation of valpha14 nkt cell-mediated cytotoxicity by interleukin 4 in
an autocrine mechanism resulting in the development of concanavalin a-
induced hepatitis. J Exp Med. 2000;191:105e114.
(8) Liu C, Gao S, Qu Z, Wang Q, Zhu F, Guo C, et al. Ncpp treatment alleviates cona-
induced hepatitis via reducing CD4þ T activation and no production. Immu-
nopharmacol Immunotoxicol. 2012;34:962e967.
(9) Bozza M, Bliss JL, Maylor R, Erickson J, Donnelly L, Bouchard P, et al. Inter-
leukin-11 reduces t-cell-dependent experimental liver injury in mice. Hep-
atology. 1999;30:1441e1447.
K.-F. Zhai et al. / Journal of Pharmacological Sciences 130 (2016) 94e100100(10) Zhou Y, Dai W, Lin C, Wang F, He L, Shen M, et al. Protective effects of
necrostatin-1 against concanavalin a-induced acute hepatic injury in mice.
Mediat Inﬂamm. 2013;2013:706156.
(11) Xu X, Hu Y, Zhai X, Lin M, Chen Z, Tian X, et al. Salvianolic acid a pre-
conditioning confers protection against concanavalin a-induced liver injury
through sirt1-mediated repression of p66shc in mice. Toxicol Appl Pharmacol.
2013;273:68e76.
(12) Xu J, Zhang X, Monestier M, Esmon NL, Esmon CT. Extracellular histones are
mediators of death through TLR2 and TLR4 in mouse fatal liver injury.
J Immunol. 2011;187:2626e2631.
(13) Kim HY, Kim JK, Choi JH, Jung JY, Oh WY, Kim DC, et al. Hepatoprotective
effect of pinoresinol on carbon tetrachloride-induced hepatic damage in mice.
J Pharmacol Sci. 2010;112:105e112.
(14) Liew FY, Xu D, Brint EK, O'Neill LA. Negative regulation of toll-like receptor-
mediated immune responses. Nat Rev Immunol. 2005;5:446e458.
(15) Guven-Maiorov E, Keskin O, Gursoy A, Nussinov R. A structural view of
negative regulation of the toll-like receptor-mediated inﬂammatory pathway.
Biophys J. 2015;109:1214e1226.
(16) Takeuchi O, Akira S. Pattern recognition receptors and inﬂammation. Cell.
2010;140:805e820.
(17) Lian LH, Jin X, Wu YL, Cai XF, Lee JJ, Nan JX. Hepatoprotective effects of Sedum
sarmentosum on D-galactosamine/lipopolysaccharide-induced murine
fulminant hepatic failure. J Pharmacol Sci. 2010;114:147e157.
(18) Qian H, Shi J, Fan TT, Lv J, Chen SW, Song CY, et al. Sophocarpine attenuates
liver ﬁbrosis by inhibiting the TLR4 signaling pathway in rats. World J Gas-
troenterol. 2014;20:1822e1832.
(19) Tu CT, Han B, Yao QY, Zhang YA, Liu HC, Zhang SC. Curcumin attenuates
concanavalin a-induced liver injury in mice by inhibition of toll-like receptor
(TLR) 2, TLR4 and TLR9 expression. Int Immunopharmacol. 2012;12:151e157.
(20) Sahin H, Borkham-Kamphorst E, do ON, Berres ML, Kaldenbach M,
Schmitz P, et al. Proapoptotic effects of the chemokine, cxcl 10 are mediatedby the noncognate receptor TLR4 in hepatocytes. Hepatology. 2013;57:
797e805.
(21) Tiegs G, Kusters S, Kunstle G, Hentze H, Kiemer AK, Wendel A. Ebselen pro-
tects mice against t cell-dependent, TNF-mediated apoptotic liver injury.
J Pharmacol Exp Ther. 1998;287:1098e1104.
(22) Song B, Huang G, Tong C, Li G, Wang Z, Xiong Y, et al. Gossypol suppresses
mouse t lymphocytes via inhibition of nfkappab, nfat and ap-1 pathways.
Immunopharmacol Immunotoxicol. 2013;35:615e621.
(23) Li Y, Wang ZL, He F, Wu Y, Huang W, He Y, et al. Tp-58, a novel thienopyridine
derivative, protects mice from concanavalina-induced hepatitis by suppress-
ing inﬂammation. Cell Physiol Biochem. 2012;29:31e40.
(24) Liu W, Ogata T, Sato S, Unoura K, Onodera J. Superoxide scavenging activities
of sixty chinese medicines determined by an esr spin-trapping method using
electrogenerated superoxide. Yakugaku Zasshi. 2001;121:265e270.
(25) Ma XH, Zhao YC, Yin L, Han DW, Ji CX. Studies on the effect of oleanolic acid on
experimental liver injury. Acta Pharm Sin B. 1982;17:93e97.
(26) Nagao Y, Ye MR, Lin CZ, Zhu CC, Lai XP. Protective effect of isodon lophan-
thoides var. Gerardianus on acute hepatic injury induced by carbon tetra-
chloride in rats. China J Chin Materia Medica. 2006;31:574e577.
(27) Shirin H, Aeed H, Alin A, Matas Z, Kirchner M, Brazowski E, et al. Inhibition of
immune-mediated concanavalin a-induced liver damage by free-radical
scavengers. Dig Dis Sci. 2010;55:268e275.
(28) Kubota K, Saiwai H, Kumamaru H, Maeda T, Ohkawa Y, Aratani Y, et al.
Myeloperoxidase exacerbates secondary injury by generating highly reactive
oxygen species and mediating neutrophil recruitment in experimental spinal
cord injury. Spine. 2012;37:1363e1369.
(29) Cengiz M, Ozenirler S, Elbeg S. Role of serum toll-like receptors 2 and 4 in
non-alcoholic steatohepatitis and liver ﬁbrosis. J Gastroenterol Hepatol.
2015;30:1190e1196.
(30) Liu J. Oleanolic acid and ursolic acid: research perspectives. J Ethnopharmacol.
2005;100:92e94.
